Dopamine agonist bromocriptine for the prevention of ovarian hyperstimulation syndrome.
Author(s): Spitzer D, Wogatzky J, Murtinger M, Zech MH, Haidbauer R, Zech NH
Affiliation(s): IVF Centers Prof. Zech, Salzburg, Austria.
Publication date & source: 2011-06-30, Fertil Steril., 95(8):2742-4.e1. Epub 2011 Mar 15.
The aim of this retrospective study is to investigate the frequency and severity of ovarian hyperstimulation syndrome and the pregnancy rate in a patient collective at risk who received bromocriptine treatment. Copyright (c) 2011 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.
|